Heart Disease Clinical Trials in New York

Showing 81-100 of 575 trials

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

NCT07335510

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to assess how therapy using this device affects heart function, symptoms, and exercise capacity, with particular focus on how the device affects blood flow and heart pressures during exercise. Information from this study may help inform patient selection and device management in patients with heart failure.

HFrEF - Heart Failure With Reduced Ejection Fraction

Columbia University58 participantsStarted Jan 2026

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +4 more locations

Active Not RecruitingNA< 1 mile

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

NCT05268094

COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life.

Congenital Heart Disease in Children

Carelon Research300 participantsStarted Jun 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +21 more locations

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Heart Disease Trials in Other Cities

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Subspecialty Ambulatory Quality Cardiology Program

A Extension Study of Udenafil in Adolescents

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

SyncAV Post-Market Trial

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Sapphire 3 CTO Study

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Other Conditions in New York